Market Overview:
The global AI in remote patient monitoring market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing incidence of chronic diseases, rising demand for home-based healthcare, and growing adoption of AI in remote patient monitoring. Based on type, the global AI in remote patient monitoring market is segmented into whole exome sequencing, whole genome sequencing, vital monitors, targeted sequencing & resequencing. The whole genome sequencing segment is expected to grow at the highest CAGR during the forecast period from 2018 to 2030. This growth can be attributed to the increasing demand for personalized medicine and growing focus on precision medicine. Based on application, the global AI in remote patient monitoring market is segmented into cancer care, heart disorders care (cardiovascular diseases and arrhythmia), diabetes care (diabetes mellitus type 1 and 2), sleep apnea care (obstructive sleep apnea syndrome), respiratory problems care (chronic obstructive pulmonary disease [COPD] and asthma) and other applications (neurological disorders such as Alzheimer’s disease).
Product Definition:
The term "AI in Remote Patient Monitoring" typically refers to the use of artificial intelligence algorithms to automatically analyze data collected from patients remotely, in order to detect early signs of health problems. The importance of AI in Remote Patient Monitoring is that it can help identify health problems earlier, which can lead to more effective treatment.
Whole Exome:
Whole exome is a project to collect all human genome data in an effort to find the cure for any disease. It includes data from protein-coding regions (exomes) of humans, as well as non-coding regions (transcripts). Whole exome was first started by the Human Genome Project and has been carried on since then with various advancements.
Whole Genome:
The global whole genome and it's usage in AI in the remote patient monitoring market size was valued at USD 6.1 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 19.7% from 2019 to 2023. Increasing prevalence of chronic diseases, such as diabetes, cancer, cardiovascular diseases along with rising geriatric population are some high impact rendering drivers for the market growth over the forecast period.
Application Insights:
The cancer segment dominated the global market in 2017. This can be attributed to the rising prevalence of cancer and increasing investments for R&D in this sector. For instance, last year, a company named NantKwest received FDA approval for its Nanobot-based System for Cancer Detection (Nanoleafleaflet) as an oncology tool. The system is designed to help identify biomarkers associated with lung, breast and other cancers by detecting circulating tumor cells (CTCs).
The heart disorders segment is expected to witness lucrative growth over the forecast period due to increasing incidence of cardiovascular diseases (CVDs) globally coupled with technological advancements in remote patient monitoring systems that are specifically designed for patients suffering from cardiac disorders. For instance, In April 2018, U.S.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased adoption of advanced technologies, and high healthcare expenditure in this region. Moreover, increasing demand for remote patient monitoring services due to rising geriatric population is expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and growing target population base with unmet needs for diagnosis & treatment leading into disorders that require continuous medical supervision & care.
Growth Factors:
- Increasing demand for AI in remote patient monitoring from the healthcare sector to improve the quality of care and reduce costs.
- Growing number of AI startups that are developing innovative solutions for remote patient monitoring, which is expected to drive market growth over the next few years.
- Rising adoption of telemedicine and mHealth technologies, which is helping to expand the reach of AI-based remote patient monitoring solutions.
- Proliferation of big data and analytics platforms that are helping healthcare organizations make better use of data generated by remote patient monitoring systems for clinical decision-making purposes.
Scope Of The Report
Report Attributes
Report Details
Report Title
AI In Remote Patient Monitoring Market Research Report
By Type
Whole Exome, Whole Genome, Vital Monitors, Targeted Sequencing & Resequencing
By Application
Cancer, Heart Disorders, Diabetes, Sleep Apnea, Respiratory Problems
By Companies
Atomwise, International Business Machines, Berg, Zebra Medical Vision, Modernizing Medicine, Caption Health, Sense.ly, AiCure, Medasense Biometrics, Nuance Communications
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global AI In Remote Patient Monitoring Market Report Segments:
The global AI In Remote Patient Monitoring market is segmented on the basis of:
Types
Whole Exome, Whole Genome, Vital Monitors, Targeted Sequencing & Resequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Heart Disorders, Diabetes, Sleep Apnea, Respiratory Problems
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Atomwise
- International Business Machines
- Berg
- Zebra Medical Vision
- Modernizing Medicine
- Caption Health
- Sense.ly
- AiCure
- Medasense Biometrics
- Nuance Communications
Highlights of The AI In Remote Patient Monitoring Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Whole Exome
- Whole Genome
- Vital Monitors
- Targeted Sequencing & Resequencing
- By Application:
- Cancer
- Heart Disorders
- Diabetes
- Sleep Apnea
- Respiratory Problems
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the AI In Remote Patient Monitoring Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
AI is a technology that can be used in remote patient monitoring to help doctors and nurses monitor patients. AI can help doctors and nurses identify problems early, which could save the patient's life.
Some of the major players in the ai in remote patient monitoring market are Atomwise, International Business Machines, Berg, Zebra Medical Vision, Modernizing Medicine, Caption Health, Sense.ly, AiCure, Medasense Biometrics, Nuance Communications.
The ai in remote patient monitoring market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 AI In Remote Patient Monitoring Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 AI In Remote Patient Monitoring Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 AI In Remote Patient Monitoring Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the AI In Remote Patient Monitoring Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global AI In Remote Patient Monitoring Market Size & Forecast, 2020-2028
4.5.1 AI In Remote Patient Monitoring Market Size and Y-o-Y Growth
4.5.2 AI In Remote Patient Monitoring Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Whole Exome
5.2.2 Whole Genome
5.2.3 Vital Monitors
5.2.4 Targeted Sequencing & Resequencing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Heart Disorders
6.2.3 Diabetes
6.2.4 Sleep Apnea
6.2.5 Respiratory Problems
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global AI In Remote Patient Monitoring Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 AI In Remote Patient Monitoring Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Whole Exome
9.6.2 Whole Genome
9.6.3 Vital Monitors
9.6.4 Targeted Sequencing & Resequencing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Heart Disorders
9.10.3 Diabetes
9.10.4 Sleep Apnea
9.10.5 Respiratory Problems
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Whole Exome
10.6.2 Whole Genome
10.6.3 Vital Monitors
10.6.4 Targeted Sequencing & Resequencing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Heart Disorders
10.10.3 Diabetes
10.10.4 Sleep Apnea
10.10.5 Respiratory Problems
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Whole Exome
11.6.2 Whole Genome
11.6.3 Vital Monitors
11.6.4 Targeted Sequencing & Resequencing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Heart Disorders
11.10.3 Diabetes
11.10.4 Sleep Apnea
11.10.5 Respiratory Problems
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Whole Exome
12.6.2 Whole Genome
12.6.3 Vital Monitors
12.6.4 Targeted Sequencing & Resequencing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Heart Disorders
12.10.3 Diabetes
12.10.4 Sleep Apnea
12.10.5 Respiratory Problems
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Whole Exome
13.6.2 Whole Genome
13.6.3 Vital Monitors
13.6.4 Targeted Sequencing & Resequencing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Heart Disorders
13.10.3 Diabetes
13.10.4 Sleep Apnea
13.10.5 Respiratory Problems
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 AI In Remote Patient Monitoring Market: Competitive Dashboard
14.2 Global AI In Remote Patient Monitoring Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Atomwise
14.3.2 International Business Machines
14.3.3 Berg
14.3.4 Zebra Medical Vision
14.3.5 Modernizing Medicine
14.3.6 Caption Health
14.3.7 Sense.ly
14.3.8 AiCure
14.3.9 Medasense Biometrics
14.3.10 Nuance Communications
